Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT00950144
What this trial is testing

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Who this might be right for
Colorectal CancerDepressionFatigue+3 more
City of Hope Medical Center 123
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Not applicableStudy completedNCT01910909
What this trial is testing

Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Samsung Medical Center 56
Not applicableNot Yet RecruitingNCT06069947
What this trial is testing

SALT for Liver Cirrhosis With HCC

Who this might be right for
HCCLiver Cirrhosis
RenJi Hospital 40
Very early researchStudy completedNCT02013492
What this trial is testing

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Male Breast CancerRecurrent MelanomaStage IV Breast Cancer+5 more
William Carson 1
Not applicableEnded earlyNCT00469963
What this trial is testing

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Vanderbilt-Ingram Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00052364
What this trial is testing

Oxaliplatin in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 32
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Not applicableLooking for participantsNCT07345247
What this trial is testing

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

Who this might be right for
Liver Cancer, Adult
Ankara University 150
Testing effectiveness (Phase 2)WithdrawnNCT00003714
What this trial is testing

Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004248
What this trial is testing

Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Roswell Park Cancer Institute 24
Not applicableLooking for participantsNCT07751783
What this trial is testing

Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations

Who this might be right for
CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Lung Cancer (Non-Small Cell)+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 150
Not applicableStudy completedNCT00482586
What this trial is testing

Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Who this might be right for
Liver CancerMetastatic Cancer
Vanderbilt University 137
Not applicableStudy completedNCT02072486
What this trial is testing

Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Hepatocellular CarcinomaStage III Childhood Hepatocellular Carcinoma+6 more
Roswell Park Cancer Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT07500220
What this trial is testing

Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer
Beijing Biotech 30
Early research (Phase 1)Ended earlyNCT04502082
What this trial is testing

Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more
Eureka Therapeutics Inc. 8
Not applicableEnded earlyNCT02527577
What this trial is testing

Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection.

Who this might be right for
Liver Cancer, Adult
Centre Hospitalier Universitaire de Saint Etienne 39
Large-scale testing (Phase 3)Study completedNCT00109954
What this trial is testing

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Pittsburgh 120
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Next Page